Back to search

Ireland· IE-PA-PA22641/002/001

GRANOCYTE 34 million IU/mL, powder and solvent for solution for injection/infusion, in a pre-filled syringe

A lenograstim product containing lenograstim, registered in Ireland by Chugai Pharma France. The same ATC class is registered in 8 of our 19 countries.

ATC L03AA10

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedGRANOCYTE 34 million IU/mL, powder an…ATCL03AA10REGISTER NO.IE-PA-PA22641/002/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Lenograstim is registered in 8 of 19 countries.

Countries holding a registration under ATC L03AA10 (lenograstim), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 5 of them publish a price we can compare per daily dose

Lenograstim · ATC L03AA10

8 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Lenograstim
Manufacturer
Chugai Pharma France
Country
Ireland (IE)
ATC code
L03AA10
ATC class
Lenograstim
Defined daily dose
0.35 mg, P
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA22641/002/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lenograstim in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lenograstim products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Belgium · Granocyte
  • Germany · Granocyte
  • France · Granocyte
  • United Kingdom (Northern Ireland) · Granocyte
  • Luxembourg · Granocyte
  • Sweden · Granocyte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b33ea879-e81d-4430-8683-6040da02a2ff
GET /v1/drugs/b33ea879-e81d-4430-8683-6040da02a2ff?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder and solvent for solution for injection/infusion",
  "routes": [
    "Intravenous use"
  ],
  "source": "hpra",
  "atc_all": [
    "L03AA",
    "L03AA10"
  ],
  "strength": null,
  "pa_number": "PA22641/002/001",
  "substances": [
    "Lenograstim"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "01/09/2009",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about lenograstim.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.